DOW JONES27,973.27-1019.14 -3.52%
S&P 5003,221.48-116.27 -3.48%
NASDAQ9,229.36-347.23 -3.63%

CFRA Maintains Sell on Edwards Lifesciences, Raises Price Target to $207

CFRA analyst Kevin Huang maintains Edwards Lifesciences (NYSE:EW) with a Sell and raises the price target from $205 to $207.

Benzinga · 01/31/2020 17:09

CFRA analyst Kevin Huang maintains Edwards Lifesciences (NYSE:EW) with a Sell and raises the price target from $205 to $207.